Frank Zavrl serves as Executive at PUMA BIOTECHNOLOGY, INC., where they oversee executive responsibilities. Since joining the company, Frank Zavrl has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 9, 2020 involved receiving (via award) 25,748 shares valued at $0.
Frank Zavrl currently holds 50,993 shares of PUMA BIOTECHNOLOGY, INC. (PBYI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Frank Zavrl has been a net neutral trader of PBYI stock. They have purchased $0 and sold $0 worth of shares.
Frank Zavrl's most recent insider trade was on Jun 9, 2020, when they sold 25,748 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 12, 2018 | PBYI | $0 | Award | 5,822 | $N/A | Discretionary |